These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23298417)

  • 21. Toward the active conformations of rhodopsin and the beta2-adrenergic receptor.
    Gouldson PR; Kidley NJ; Bywater RP; Psaroudakis G; Brooks HD; Diaz C; Shire D; Reynolds CA
    Proteins; 2004 Jul; 56(1):67-84. PubMed ID: 15162487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping functional group free energy patterns at protein occluded sites: nuclear receptors and G-protein coupled receptors.
    Lakkaraju SK; Yu W; Raman EP; Hershfeld AV; Fang L; Deshpande DA; MacKerell AD
    J Chem Inf Model; 2015 Mar; 55(3):700-8. PubMed ID: 25692383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Observation of "ionic lock" formation in molecular dynamics simulations of wild-type beta 1 and beta 2 adrenergic receptors.
    Vanni S; Neri M; Tavernelli I; Rothlisberger U
    Biochemistry; 2009 Jun; 48(22):4789-97. PubMed ID: 19378975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular modeling of the human serotonin(1A) receptor: role of membrane cholesterol in ligand binding of the receptor.
    Paila YD; Tiwari S; Sengupta D; Chattopadhyay A
    Mol Biosyst; 2011 Jan; 7(1):224-34. PubMed ID: 20967314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformational complexity of G-protein-coupled receptors.
    Kobilka BK; Deupi X
    Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the role of Asp79(2.50) in β2 adrenergic receptor activation from molecular dynamics simulations.
    Ranganathan A; Dror RO; Carlsson J
    Biochemistry; 2014 Nov; 53(46):7283-96. PubMed ID: 25347607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
    Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand entry and exit pathways in the beta2-adrenergic receptor.
    Wang T; Duan Y
    J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand-binding affinity of alternative conformers of human β
    Dilcan G; Doruker P; Akten ED
    Chem Biol Drug Des; 2019 May; 93(5):883-899. PubMed ID: 30637937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of cholesterol binding sites in the serotonin1A receptor.
    Sengupta D; Chattopadhyay A
    J Phys Chem B; 2012 Nov; 116(43):12991-6. PubMed ID: 23067252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsecond Molecular Dynamics Simulations Provide Insight into the Allosteric Mechanism of the Gs Protein Uncoupling from the β2 Adrenergic Receptor.
    Sun X; Ågren H; Tu Y
    J Phys Chem B; 2014 Dec; 118(51):14737-44. PubMed ID: 25453446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors.
    Rodríguez D; Piñeiro Á; Gutiérrez-de-Terán H
    Biochemistry; 2011 May; 50(19):4194-208. PubMed ID: 21480628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Principles of Ligand Specificity on beta-2-adrenergic receptor.
    Chan HC; Filipek S; Yuan S
    Sci Rep; 2016 Oct; 6():34736. PubMed ID: 27703221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into the conformational perturbations of novel agonists with β3-adrenergic receptor using molecular dynamics simulations.
    Tewatia P; Agrawal N; Gaur M; Sahi S
    Biochimie; 2014 Jun; 101():168-82. PubMed ID: 24508605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-based and in-silico studies on the high intrinsic activity of two boron-containing salbutamol derivatives at the human β₂-adrenoceptor.
    Soriano-Ursúa MA; McNaught-Flores DA; Nieto-Alamilla G; Segura-Cabrera A; Correa-Basurto J; Arias-Montaño JA; Trujillo-Ferrara JG
    Bioorg Med Chem; 2012 Jan; 20(2):933-41. PubMed ID: 22182578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.
    Zhu Y; Yuan Y; Xiao X; Zhang L; Guo Y; Pu X
    J Mol Model; 2014 Nov; 20(11):2491. PubMed ID: 25342155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of lipid-mediated effects in β₂-adrenergic receptor dimerization.
    Prasanna X; Chattopadhyay A; Sengupta D
    Adv Exp Med Biol; 2015; 842():247-61. PubMed ID: 25408348
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug design strategies for targeting G-protein-coupled receptors.
    Klabunde T; Hessler G
    Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential Application of Alchemical Free Energy Simulations to Discriminate GPCR Ligand Efficacy.
    Lee HS; Seok C; Im W
    J Chem Theory Comput; 2015 Mar; 11(3):1255-66. PubMed ID: 26579772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of cholesterol recognition amino acid consensus (CRAC) motif in G-protein coupled receptors.
    Jafurulla M; Tiwari S; Chattopadhyay A
    Biochem Biophys Res Commun; 2011 Jan; 404(1):569-73. PubMed ID: 21146498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.